Form: 3

Initial statement of beneficial ownership of securities

January 6, 2009

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Jacobsen Stein
(Last) (First) (Middle)
RESMED INC.
14040 DANIELSON STREET
(Street)
POWAY CA 92064
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/02/2009 		3. Issuer Name and Ticker or Trading Symbol
RESMED INC [ RMD ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
COO, Europe
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
ResMed Common Stock 23,699.329 D
ResMed Common Stock 40,000 I Stein Jacobsen Invest AS
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
ResMed Common Stock Options 02/03/2007(1) 02/03/2016 ResMed Common Stock 12,000 38.5 D
ResMed Common Stock Options 11/10/2007(1) 11/10/2013 ResMed Common Stock 12,000 46.19 D
ResMed Common Stock Options 08/01/2008(1) 08/01/2014 ResMed Common Stock 25,000 43.42 D
ResMed Common Stock Options 11/07/2008(1) 11/07/2014 ResMed Common Stock 4,000 42.05 D
ResMed Common Stock Options 10/01/2009(1) 10/01/2015 ResMed Common Stock 10,000 43.35 D
ResMed Common Stock Options 11/20/2009(1) 11/20/2015 ResMed Common Stock 70,000 31.04 D
Explanation of Responses:
1. Stock options vest 1/4 per year on the anniversary of the grant.
Remarks:
Stein Jacobsen 01/05/2009
** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.